Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and E-Cigarettes Among Daily and Non-Daily Smokers
NCT02964182Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2017
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of cigarette reduced nicotine in nicotine dependence (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Usual Brand Cigarettes Per Day, Very Low Nicotine Content Cigarettes Per Day and 1 more. Started Oct 2017; status: completed.
02
Drugs
cigarette reduced nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02964182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02964182.